Ma Siyuan, Yan Junyu, Chen Lu, Zhu Yingqi, Chen Kaitong, Zheng Cankun, Shen Mengjia, Liao Yulin
State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Shock and Microcirculation, Department of Cardiology, National Clinical Research Center of Kidney Disease, Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Front Cardiovasc Med. 2021 Dec 13;8:789503. doi: 10.3389/fcvm.2021.789503. eCollection 2021.
Recent research has suggested that cardiac regeneration may have the widely applicable potential of treating heart failure (HF). A comprehensive understanding of the development status of this field is conducive to its development. However, no bibliometric analysis has summarized this field properly. We aimed to analyze cardiac regeneration-related literature over 20 years and provide valuable insights. Publications were collected from the Web of Science Core Collection (WoSCC). Microsoft Excel, VOSviewer, CiteSpace, and alluvial generator were used to analyze and present the data. The collected 11,700 publications showed an annually increasing trend. The United States and Harvard University were the leading force among all the countries and institutions. The majority of articles were published in Circulation Research, and Circulation was the most co-cited journal. According to co-citation analysis, burst detection and alluvial flow map, cardiomyocyte proliferation, stem cells, such as first-and second-generation, extracellular vesicles especially exosomes, direct cardiac reprogramming, macrophages, microRNAs, and inflammation have become more and more popular recently. Cardiac regeneration remains a research hotspot and develops rapidly. How to modify cardiac regeneration endogenously and exogenously may still be the hotspot in the future and should be discussed more deeply.
Front Cardiovasc Med. 2021-12-13
Front Cardiovasc Med. 2021-8-25
Front Pharmacol. 2020-9-15
Front Cardiovasc Med. 2022-7-12
Medicine (Baltimore). 2023-8-25
J Bioenerg Biomembr. 2023-2
Front Cell Infect Microbiol. 2022
Front Med (Lausanne). 2022-7-22
Stem Cell Rev Rep. 2022-8
Front Pharmacol. 2020-9-15
Exp Mol Med. 2019-12-19
J Int Med Res. 2019-11
BMC Complement Altern Med. 2019-8-22
Curr Opin Cell Biol. 2019-8-10
Cell Mol Life Sci. 2018-12-21
Cell Physiol Biochem. 2018
Int J Environ Res Public Health. 2018-7-26
Am J Physiol Heart Circ Physiol. 2018-6-27